News search
 Research 7 Jul 2026 Hypertrophic cardiomyopathy is the most common inherited heart disease and the leading cause of sudden cardiac death in young people and athletes |
 Research 1 Jul 2026 The findings provide new insights for developing strategies aimed at preventing the cardiovascular complications associated with this rare disease |
 About the CNIC 11 Jun 2026 The meeting forms part of European awareness-raising activities around the European Commission’s new strategy to strengthen prevention, early detection, and management of cardiovascular disease |
 |
 Research 28 May 2026 The findings, published in Cardiovascular Research, show that the right ventricle has greater metabolic resilience than the left during cardiac arrest caused by ventricular fibrillation. |
 Research 23 Apr 2026 Job Verdonschot, Maastricht University Medical Center, and the Cardiovascular Research Institute Maastricht |
 Research 21 Apr 2026 CNIC scientists identify a biomarker that improves risk prediction in a severe form of heart failure The biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events. |
 Research 15 Apr 2026 Scientist at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and the Institute for Research in Biomedicine (IRB Barcelona) uncover a key metabolic mechanism governing immune cell readiness |
 About the CNIC 31 Mar 2026 The initiative will combine innovative medical and digital technologies to improve the early detection of cardiac risk and complications in cancer patients and survivors |
 Research 5 Feb 2026 A prespecified landmark analysis of the REBOOT trial, published in The European Heart Journal Cardiovascular Pharmacotherapy, shows no clinical benefit of beta-blockers during the first year after infarction or beyond one year, in patients without reduced ejection fraction. |
- ‹ previous
- 2 of 19
- next ›
